Keynote Speakers

 

 
     
Greg Anderson
Vice President, Corporate Research Lab
3M Company

Greg Anderson is the Vice President of 3M's Corporate Research Lab. The Corporate Research Lab is responsible for development and deployment of new technology across the global 3M R&D organization.

Greg joined 3M in 1993 as a research chemist in the then Adhesive Technologies Center, Corporate Research Lab. Greg was part of the Corporate R&D organization at 3M working on multiple adhesive platforms before transferring to the Office Supplies division in 2000 as a Senior Technical Manager. Within this capacity, Greg was responsible for Post It branded products, and in 2003, Greg was appointed the Technical Director for the Office Supplies Division. In 2007, he joined the Automotive Division, Industrial and Transportation Business as a Technical Director and worked with his team to develop and commercialize new adhesives, trim film and ceramic fiber composites. In 2010, Greg joined 3M's Skin & Would Care Division/Critical & Chronic Care Solutions Division, Health Care Business as the Technical Director and Clinical Research. Within this capacity, Greg was responsible for commercializing the Silicone Platform and developing a number of programs within advanced wound care space

Greg has a M.B.A. in Marketing from the University of St. Thomas, M.S. in Organic Chemistry from the University of Minnesota, and a B.S. in chemistry from Hamline University in St. Paul MN.

At the center of 3M lies the Corporate Research Laboratories (CRL). This group is interdisciplinary by design and partners with Business Group Laboratories to deploy new technologies and capabilities through the commercialization of new products. CRL is the steward for 3M's technology platforms and is leading efforts to sponsor research programs with Universities and external entities. One of the focused areas of research is engineered biomaterials. Sponsored research programs are critical for engineered biomaterials in order to better understand biological systems and how these materials trigger a defined biological response. Applications such as biopharma purification, wound healing, sterilization, re-mineralization, etc. require unique engineered biomaterials and an eco-system that helps us understand the efficacy of these materials in their directed application. All of these important applications benefit from the CRL model within 3M as will be further introduced in this talk.

     
Dr. Sebastian Eriksson Giwa
Cofounder of Elevian, Sylvatica Biotech, Ossium Health and the Organ Preservation Alliance

In many ways, the strengths of industry are exactly the weaknesses of academia and vice versa. By creating new structures that leverage the best of both academia and industry, larger scale problems can be tackled with significant resources in a way that leads to i) breakthrough science, ii) rapid technological translation and high odds of commercialization. In this talk we'll explore roadmaps for such structures based on concrete past examples and future initiatives in the works.

Sebastian will draw from experience from biotech companies Sylvatica Biotech, Ossium Health, and Elevian Inc as well as from the non-profit Organ Preservation Alliance - all four that he co-founded and was/is a leader of.

Prior experience includes investing and research at leading hedge fund, Bridgewater Associates, consulting and research at Bain and Goldman Sachs and serving two terms as the President of the National Youth Council of Sweden. Sebastian holds a PhD in Economics (conducted at SSE, Harvard and MIT) and an MBA from Harvard where he graduated with High Distinction and was named a Baker Scholar.

     
Dr. David M. Knapp
Vice President of Corporate Research
Boston Scientific
 

David Knapp is a leader in the area of Medical Device Development and Exploratory Research working to treat unmet clinical needs for 20 years. Dave's current focus as Vice President of Corporate Research at Boston Scientific is on developing new solutions and fostering growth in White Space areas of the company and developing novel technical platforms that cut across all Boston Scientific Divisions. He is passionate about coordinating open collaborative efforts including developing relationships with external institutions and connecting functions to drive meaningful innovation. Dave also serves as a Board Member on the Boston Scientific Foundation and is a member of the Boston Scientific Health Advisory Panel. He holds a B.S. in Chemical Engineering from University of Michigan and a Ph.D. in Chemical Engineering from University of Minnesota where he is a Fellow of the Institute for Engineering in Medicine.

       

↑ Top                        

 

 

 

 

 

 

 

 

 

 

 

 

                       


 

 

Copyright © 2016 The Regents of the University of Minnesota - All rights reserved.